Susquehanna International Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64M | Buy |
48,834
+27,337
| +127% | +$1.52M | ﹤0.01% | 5543 |
|
|
2025
Q4 | $1.2M | Sell |
21,497
-37,171
| -63% | -$1.93M | ﹤0.01% | 6770 |
|
|
2025
Q3 | $2.81M | Sell |
58,668
-15,207
| -21% | -$680K | ﹤0.01% | 5099 |
|
|
2025
Q2 | $3M | Sell |
73,875
-18,170
| -20% | -$730K | ﹤0.01% | 4958 |
|
|
2025
Q1 | $4.03M | Buy |
92,045
+43,146
| +88% | +$1.9M | ﹤0.01% | 4063 |
|
|
2024
Q4 | $2.1M | Buy |
48,899
+35,136
| +255% | +$1.6M | ﹤0.01% | 5208 |
|
|
2024
Q3 | $611K | Sell |
13,763
-24,229
| -64% | -$1.04M | ﹤0.01% | 7986 |
|
|
2024
Q2 | $1.51M | Sell |
37,992
-9,557
| -20% | -$387K | ﹤0.01% | 5651 |
|
|
2024
Q1 | $2.05M | Buy |
47,549
+30,230
| +175% | +$1.3M | ﹤0.01% | 5273 |
|
|
2023
Q4 | $721K | Sell |
17,319
-28,427
| -62% | -$1.08M | ﹤0.01% | 7789 |
|
|
2023
Q3 | $1.82M | Buy |
45,746
+383
| +0.8% | +$16.2K | ﹤0.01% | 5314 |
|
|
2023
Q2 | $1.86M | Buy |
45,363
+24,447
| +117% | +$1.01M | ﹤0.01% | 5300 |
|
|
2023
Q1 | $858K | Sell |
20,916
-17,776
| -46% | -$747K | ﹤0.01% | 7223 |
|
|
2022
Q4 | $1.58M | Buy |
38,692
+33,509
| +647% | +$1.39M | ﹤0.01% | 5160 |
|
|
2022
Q3 | $208K | Sell |
5,183
-553
| -10% | -$23.6K | ﹤0.01% | 10739 |
|
|
2022
Q2 | $241K | Sell |
5,736
-31,121
| -84% | -$1.31M | ﹤0.01% | 10162 |
|
|
2022
Q1 | $1.67M | Sell |
36,857
-13,993
| -28% | -$615K | ﹤0.01% | 5880 |
|
|
2021
Q4 | $2.35M | Buy |
50,850
+19,309
| +61% | +$915K | ﹤0.01% | 5129 |
|
|
2021
Q3 | $1.5M | Sell |
31,541
-6,634
| -17% | -$330K | ﹤0.01% | 6492 |
|
|
2021
Q2 | $1.98M | Buy |
38,175
+10,927
| +40% | +$549K | ﹤0.01% | 5942 |
|
|
2021
Q1 | $1.37M | Buy |
27,248
+22,301
| +451% | +$1.19M | ﹤0.01% | 6896 |
|
|
2020
Q4 | $258K | Sell |
4,947
-5,897
| -54% | -$282K | ﹤0.01% | 9574 |
|
|
2020
Q3 | $471K | Buy |
10,844
+3,031
| +39% | +$133K | ﹤0.01% | 7815 |
|
|
2020
Q2 | $336K | Sell |
7,813
-7,400
| -49% | -$306K | ﹤0.01% | 8158 |
|
|
2020
Q1 | $549K | Buy |
+15,213
| New | +$648K | ﹤0.01% | 6736 |
|
|
2019
Q4 | – | Sell |
-32,753
| Closed | -$1.3M | – | 10787 |
|
|
2019
Q3 | $1.17M | Buy |
32,753
+2,183
| +7% | +$81.2K | ﹤0.01% | 5355 |
|
|
2019
Q2 | $1.22M | Buy |
+30,570
| New | +$1.2M | ﹤0.01% | 5215 |
|
|
2019
Q1 | – | Sell |
-61,079
| Closed | -$2.48M | – | 9978 |
|
|
2018
Q4 | $2.24M | Buy |
61,079
+31,220
| +105% | +$1.33M | ﹤0.01% | 3366 |
|
|
2018
Q3 | $1.45M | Buy |
29,859
+3,078
| +11% | +$146K | ﹤0.01% | 4549 |
|
|
2018
Q2 | $1.15M | Sell |
26,781
-22,985
| -46% | -$965K | ﹤0.01% | 5041 |
|
|
2018
Q1 | $2.08M | Buy |
49,766
+16,676
| +50% | +$727K | ﹤0.01% | 3839 |
|
|
2017
Q4 | $1.44M | Buy |
33,090
+3,038
| +10% | +$129K | ﹤0.01% | 4535 |
|
|
2017
Q3 | $1.28M | Buy |
30,052
+13,627
| +83% | +$578K | ﹤0.01% | 4808 |
|
|
2017
Q2 | $707K | Buy |
16,425
+4,425
| +37% | +$187K | ﹤0.01% | 5978 |
|
|
2017
Q1 | $502K | Sell |
12,000
-3,121
| -21% | -$127K | ﹤0.01% | 6480 |
|
|
2016
Q4 | $591K | Buy |
15,121
+10,113
| +202% | +$412K | ﹤0.01% | 6630 |
|
|
2016
Q3 | $221K | Sell |
5,008
-27,693
| -85% | -$1.26M | ﹤0.01% | 7425 |
|
|
2016
Q2 | $1.37M | Buy |
32,701
+4,782
| +17% | +$203K | ﹤0.01% | 4229 |
|
|
2016
Q1 | $1.12M | Buy |
27,919
+2,986
| +12% | +$127K | ﹤0.01% | 4855 |
|
|
2015
Q4 | $1.28M | Sell |
24,933
-384,244
| -94% | -$19.6M | ﹤0.01% | 4932 |
|
|
2015
Q3 | $19.2M | Buy |
409,177
+338,927
| +482% | +$20.4M | 0.01% | 1236 |
|
|
2015
Q2 | $4.38M | Buy |
70,250
+13,970
| +25% | +$870K | ﹤0.01% | 3138 |
|
|
2015
Q1 | $3.48M | Buy |
+56,280
| New | +$3.34M | ﹤0.01% | 3293 |
|
|
2014
Q4 | – | Sell |
-26,050
| Closed | -$1.42M | – | 10170 |
|
|
2014
Q3 | $1.38M | Buy |
+26,050
| New | +$1.32M | ﹤0.01% | 5293 |
|
|
2014
Q2 | – | Sell |
-82,550
| Closed | -$3.87M | – | 10164 |
|
|
2014
Q1 | $3.87M | Sell |
82,550
-1,590
| -2% | -$75.1K | ﹤0.01% | 3261 |
|
|
2013
Q4 | $3.7M | Buy |
+84,140
| New | +$3.5M | ﹤0.01% | 3350 |
|
|
2013
Q3 | – | Sell |
-169,678
| Closed | -$5.98M | – | 8839 |
|
|
2013
Q2 | $5.98M | Buy |
+169,678
| New | +$5.73M | ﹤0.01% | 2395 |
|
Other funds holding XPH
KWM
FCBT
Susquehanna International Group's XPH Position: Q1 2026 in Review
Susquehanna International Group increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 127% in Q1 2026, buying an estimated $1.52M and bringing the position to 48,834 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #5543.
Susquehanna International Group first reported a position in XPH in Q2 2013 and has held it in 47 quarters since. The position peaked at $19.2M in Q3 2015. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.
- Susquehanna International Group held 48,834 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.64M as of Q1 2026.
- Susquehanna International Group bought 27,337 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $1.52M.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5543 holding.
- Susquehanna International Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $19.2M in Q3 2015.
- 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.